טוען...
Combined modality radioimmunotherapy: synergistic effect of Paclitaxel and additive effect of Bevacizumab
INTRODUCTION: This study was undertaken to investigate the effect of Paclitaxel and Bevacizumab on the therapeutic efficacy of (90)Y-labeled B3 mAb, directed against Le(y) antigen, for the treatment of Le(y)-positive A431 tumors implanted s.c. in the right hind flank of nude mice. METHODS: When the...
שמור ב:
| Main Authors: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3309070/ https://ncbi.nlm.nih.gov/pubmed/22172384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2011.10.020 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|